Skip Navigation
Skip to contents

ICDM 2022

Main symposia

S2 Translational research 1 :
Muscle metabolism and exercise
09:00~11:00 / Friday 7 October
Convention Hall B, 4F
Chairman:Kwanwoo Lee, Cheol Soo Choi
Overview
In this era of obesity epidemic, the need for metabolic recovery through exercise is becoming increasingly important, whose effects can be mediated by mitochondria in skeletal muscle. Four speakers will present in this session on the most recent research into novel mechanisms regulating mitochondrial function, the reciprocal relationships between exercise and mitochondria, and the resulting metabolic changes. This session will be a cornerstone to understand more precise mechanism and action of muscle metabolism related to exercise.
Mattia Quattrocelli
University of Cincinnati, USA
S2-1Two-dimensional study of drug timing to reconvert glucocorticoids into striated muscle boosters and counteract metabolic dysfunction
Zhenji Gan
Nanjing University, China
S2-2Mitochondrial plasticity and skeletal muscle fitness
Jeong-Ho Hong
Korea University, Korea
S2-3TAZ links exercise to mitochondrial biogenesis and insulin sensitivity
Il-Young Kim
Gachon University, Korea
S2-4Tracing metabolic flux in vivo using stable isotope tracers: effects of exercise training and obesity
S5 Basic Research 1 :
Adaptation of beta cell to stress
09:00~11:00 / Friday 7 October
Emerald Hall B, 3F
Chairman:Rohit N. Kulkarni , Hail Kim
Overview
Pancreatic β-cells are essential to maintain blood glucose level in response to the metabolic demand. Significant loss of functional β cell mass contributes to the development of diabetes. Therefore, maintaining functional β cell mass is crucial to treat diabetes in pathophysiological perspective. For this reason, researchers have asked questions on how β cells can respond to and compensate for metabolic stress for many years. In this session, four outstanding speakers will discuss how β-cells adapt to metabolic stress and regulate their original function when they experience cellular stress in response to metabolic stress. Prof. Jun Sung Moon and Jaemin Lee will present their recent data how oxidative stress and ER stress affect β-cell function. Prof. Rohit Kulkarni will show the significance of mRNA modification in the regulation of β-cell function. Prof. Shugo Sasaki will present his recent data about β-cell heterogeneity during neogenesis.
Jaemin Lee
DGIST, Korea
S5-1Endoplasmic reticulum stress in pancreatic β-cells induces incretin desensitization and β-cell dysfunction via ATF4
Jun Sung Moon
Yeungnam University, Korea
S5-2Therapeutic modulation of antioxidant system for damaged β-cell
Shugo Sasaki
Osaka University, Japan
S5-3Spatial and transcriptional heterogeneity of pancreatic beta cell neogenesis revealed by a time-resolved reporter system
Rohit N. Kulkarni
Harvard University, USA
S5-4The significance of mRNA modifications in the regulation of islet biology
S13 Translational research 2 :
Novel markers of the cardio-metabolic disorders
09:00~11:00 / Saturday 8 October
Emerald Hall B, 3F
Chairman:Dongsun Kim, Choon Hee Chung
Overview
Early prediction of disease onset, response rate and prognosis are becoming a major issue in managing metabolic diseases. This session is a translational session aimed to provide a novel insight for clinicians and basic researchers to tailor cardiovascular diseases and metabolic diseases in terms of biomarkers. In the session, four distinguished speakers will present their latest studies regarding novel metaboliomics/lipidmoics and other biomarkers on cardiovascular disease, non-alcoholic fatty liver diseases and etc. This session will hopefully help audiences to understand the role of novel markers in cardio-metabolic diseases.
Clemens Wittenbecher
Chalmers University of Technology, Sweden
S13-1Metabolomics profiling provides potential novel biomarkers for the impact of diet quality on cardiometabolic disease risk
Matej Orešič
Örebro University, Sweden
S13-2Lipidome in non-alcoholic fatty liver disease: pathways, metabolic models, and biomarkers
Kyung Mook Choi
Korea University, Korea
S13-3Organokines & other potential biomarkers for cardiometabolic disorders
Jin Han
Inje University, Korea
S13-4Potential molecular transducer of exercise-induced cardiac adaptation
S18 Basic Research 2 :
Adipose tissue as a moderator of systemic metabolism
13:30~15:30 / Saturday 8 October
Emerald Hall B, 3F
Chairman:Bong-Soo Cha, Byung-Hyun Park
Overview
To maintain energy balance, adipocytes switch between anabolic and catabolic metabolism, and dysregulation of this capacity has long been thought to be the origin and/or primary foe of metabolic diseases.Understanding how unhealthy adipose tissue promotes type 2 diabetes, cardiovascular disease, and certain types of cancer is critical to fighting against such diseases. Over the last two decades, scientific breakthroughs such as the discovery of brown adipose tissue in adult humans, characterization of beige/brite adipocytes in subcutaneous adipose tissue, and deconvoluting adipose heterogeneity using single-cell technologies have expanded our understanding with respect to their roles in systemic energy homeostasis. In this session, four speakers will review the current advances in adipose biology, such as the fundamental role of adipose tissue in metabolic health, the dynamic remodeling of adipose tissue, and the qualitative understanding of metabolic rate and flux in brown adipose tissues.
Jae Bum Kim
Seoul National University, Korea
S18-1Dynamic remodeling of adipose tissue for survival
Jörg Heeren
University Medical Center Hamburg-Eppendorf (UKE), Germany
S18-2Brown adipose tissue and systemic lipoprotein metabolism
John Yoon
University of California, Davis, USA
S18-3Adipose tissue and metabolic health
Su Myung Jung
Sungkyunkwan University, Korea
S18-4Metabolic flux in brown adipose tissue and its regulation by nutrient sensing pathways
Korean Diabetes Association
(04146) 101-2104, Lotte Castle President, 109 Mapo-gu, Seoul, Korea

E-mail : icdm@diabetes.or.kr

Congress Secretariat (Planbear)
#1101, 220, Gonghang-daero, Gangseo-gu, Seoul (07806), Republic of Korea
  • Korean Diabetes Association
  • 당뇨병학연구재단
  • dmj
  • 한국관광공사